96
Participants
Start Date
June 30, 2013
Primary Completion Date
March 31, 2014
Study Completion Date
March 31, 2014
Fasiglifam (TAK-875)
Fasiglifam (TAK-875) tablets
Fasiglifam (TAK-875) Placebo
Fasiglifam (TAK-875) placebo-matching tablets
Sitagliptin
Sitagliptin tablets
Sitagliptin Placebo
Sitagliptin placebo-matching tablets
Metformin
Metformin tablets
Huntsville
Chandler
Glendale
Little Rock
Fresno
Garden Grove
Modesto
San Diego
Thousand Oaks
Lakewood
Hallandale
Hialeah
Miami
Miami Lakes
North Miami
North Miami Beach
Pembroke Pines
Sanford
Atlanta
Conyers
Evans
Boise
Chicago
Evanston
Council Bluffs
Augusta
Omaha
New York
Durham
Greensboro
Hickory
Carlisle
Oklahoma City
Medford
Fort Mill
Laurens
Spartanburg
Knoxville
Austin
Odessa
San Antonio
Sugar Land
Victoria
Salt Lake City
Coronel Suárez
Ciudad Autonoma Buenos Aires
Rosario
Calgary
Red Deer
Vancouver
Victoria
Winnipeg
Etobicoke
London
Toronto
Karlovac
Krapinske Toplice
Slavonski Brod
Virovitica
Zagreb
Budapest
Gödöllő
Kistarcsa
Sátoraljaújhely
Szeged
Kelantan
Kuala Lumpur
Seri Manjung
Taiping
Taiping, Perak
Putrajaya
Ica
Lima
Cebu City
Iloilo City
Marikina City
Pasig
Quezon City
West Fairview, Quezon City
Gdansk
Lodz
Oświęcim
Rzeszów
Sobótka
Wroclaw
Zgierz
Barnaul
Kemerovo
Novosibirsk
Saint Petersburg
Bloemfontein
Pretoria
Durban
Cape Town
Bangkoknoi
Rajathevee
Muang
Klongluang
Hat Yai
Ivano-Frankivsk
Kharkiv
Kyiv
Lviv
Vinnytsia
Lead Sponsor
Takeda
INDUSTRY